During the long downturn in R&D productivity, a handful of bio-pharmaceutical companies have consistently bucked the trend. How did they manage it? After all, they have experienced the same industry pressures as their peers - pressures such as lengthier R&D cycle times, higher costs of failure, and sharper regulatory scrutiny.
While there has been much talk over the past 10 years or so about "collaboration," much of it has been focused on external supply chain collaboration. It seems that many companies neglected to get their own houses in order before looking outside their own supply chains, according to a University of Tennessee report entitled Bending the Chain: The Surprising Challenge of Integrating Purchasing and Logistics.